Full listing of the Heart Foundation Grant Recipients awarded in 2019, commencing research projects in 2020.
For any enquiries, please contact the Research Program team at [email protected]
| Institution | First Name | Last Name | Funded Amount | Scientific Title | Duration (Years) | State |
|---|---|---|---|---|---|---|
| University of Melbourne | Yee-Ming | Cheung | $85,620 | The cardiometabolic effects of endocrine therapy in postmenopausal women with oestrogen-receptor-positive breast cancer: a prospective cohort study | 3.0 | VIC |
| Monash University | Hashrul | Rashid | $40,000 | Hypoattenuated Leaflet Thickening and Leaflet Thrombosis following Transcatheter Aortic Valve Replacement | 2.3 | VIC |
| Flinders University | Angela Xun Nan | Chen | $40,000 | Understanding the adverse cardio-metabolic effects of glucocorticoids – the clinical and biological determinants. | 1.1 | SA |
| Murdoch Children's Research Institute | Gregory | King | $110,995 | Atrioventricular Valve Function During Single Ventricle Palliation | 5.4 | VIC |
| University of Sydney | Laura | Yeates | $40,000 | Caring for families affected by sudden cardiac death of a young relative (<35 years) due to genetic heart disease | 2.0 | NSW |
| University of New South Wales | Sam | Emmanuel | $89,120 | The importance of pulsatility in modern mechanical circulatory support devices | 2.2 | NSW |
| Baker Heart and Diabetes Institute | Jonathan | Sen | $40,000 | Identification and Management of Age-related Myocardial Phenotypes in Aortic Stenosis and Heart Failure with Preserved Ejection Fraction | 2.0 | VIC |
| University of Melbourne | Chee Loong | Chow | $40,000 | HISPACE: A Randomised Controlled Trial Comparing His-Bundle Pacing with Conventional Dual Chamber Pacemakers | 2.0 | VIC |
| Institution | First Name | Last Name | Funded Amount | Scientific Title | Duartion (Years) | State |
|---|---|---|---|---|---|---|
| The University of Newcastle | Michelle | Bovill | $92,450 | Non-pharamachological approaches to smoking cessation for Aboriginal and Torres Strait Islander women | 2.0 | NSW |
| Metro South Hospital and Health Service, Princess Alexandra Hospital | Sonya | Egert | $69,000 | Better Cardiac Care – hearing from the families of Indigenous cardiac patients experiencing a more culturally appropriate model of in-patient care | 1.0 | QLD |
| The University of Queensland | Andrew | Goodman | $80,700 | Using mobile-health for prevention and management of hypertension for Aboriginal & Torres Strait Islander Communities | 2.0 | QLD |
| Institution | First name | Last name | Funded Amount | Scientific Title | Duration (Years) | State |
|---|---|---|---|---|---|---|
| Australian National University | Ellie | Paige | $5,000 | Collaborative research and training in CVD risk score recalibration at the University of Cambridge | 1.0 | ACT |
| University of Western Australia | Hayley | Christian | $5,000 | Policy and practice strategies to improve young children’s physical activity and CV health | 1.0 | WA |
| Baker Heart and Diabetes Institute | Xiaowei | Wang | $5,000 | European Molecular Imaging Meeting & mastering 19F MRI | 1.0 | VIC |
| Monash University | Carol | Hodgson | $5,000 | An international program of research to improve outcomes for patients with acute heart failure | 1.0 | VIC |
| Deakin University | Lewan | Parker | $5,000 | Establishing new collaborations and techniques in Amsterdam for vascular function research | 1.0 | VIC |
| Monash University | Connie | Wong | $5,000 | Exchange at University of Bonn and attend joint ESO-WSO conference | 1.0 | VIC |
| Institution | First Name | Last Name | Funded Amount | Scientific Title | Duration (Years) | State |
|---|---|---|---|---|---|---|
| University of Sydney | Lining | Ju | $555,120 | Targeting Piezo-Integrin mechanosensing axis as an innovative, safe and effective strategy in order to reduce platelet prothrombotic phenotype in diabetes | 4.0 | NSW |
| Monash University | Dennis Thiam Leong | Wong | $385,072 | Pericoronary fat attenuation index (FAI): Novel imaging biomarker to assess vascular inflammation, risk stratify patients and guide medical therapy | 4.0 | VIC |
| Baker Heart and Diabetes Institute | Erin | Howden | $535,120 | Can exercise prevent cardiovascular dysfunction in patients treated for cancers and if so by what mechanism? | 4.0 | VIC |
| University of Western Australia | Esther | Ooi | $659,980 | Advancing translational epidemiology of cardiovascular and metabolic diseases: closing the gap on residual risk | 4.0 | WA |
| Baker Heart and Diabetes Institute | Kate | Weeks | $460,096 | Protein phosphatases: emerging drug targets for heart failure | 4.0 | VIC |
| University of Western Australia | Hayley | Christian | $659,971 | Stepping in so kids step out: Policy and practice strategies to improve young children’s physical activity to reduce obesity and optimise cardiovascular health | 4.0 | WA |
| University of Tasmania | Martin | Schultz | $535,120 | Power to the treadmill: clinical exercise physiology to improve the detection and management of high blood pressure | 4.0 | TAS |
| Monash University | Paul | Lacaze | $659,980 | Genetic protection against cardiovascular disease in the healthy elderly | 4.0 | VIC |
| Deakin University | Adrian | Cameron | $659,306 | An evidence base to support healthy supermarket interventions by retailers, policy makers and the public health community | 5.0 | VIC |
| University of Sydney | Sarah | Zaman | $535,120 | Atherosclerotic Heart Disease in Women – Sex-Specific Prevention, Recognition and Management | 4.0 | VIC |
| Griffith University | Hang | Ta | $679,980 | Smart nanomedicine with diagnostic sensor and stimuli-responsive treatment mechanisms for cardiovascular diseases | 4.0 | QLD |
| Monash University | Chengxue | Qin | $652,000 | Therapeutic Targeting of Formyl Peptide Receptors to Treat Cardiovascular Disease | 4.0 | VIC |
| Edith Cowan University | Joshua | Lewis | $659,980 | Developing & evaluating a novel tool for primary prevention of clinical cardiovascular disease. | 4.0 | WA |
| University of Technology Sydney | Sally | Inglis | $659,980 | Evaluating inequities in access to specialised care and services for people with peripheral arterial disease (PAD) in rural and remote Australia and trialling a telehealth self-care-management program for underserved PAD patients | 4.0 | NSW |
| Institution | Fulle Name | Last Name | Funded Amount | Scientific Title | Duration (Years) | State |
|---|---|---|---|---|---|---|
| Baker Heart and Diabetes Institute | Rachel | Climie | $173,850 | Novel vascular ageing biomarkers for prediction of cardiometabolic disease and related mortality in high-risk populations. | 2.0 | VIC |
| Monash University | Abdul Waheed | Khan | $153,850 | Understanding the gene environment interaction in diabetes associated atherosclerosis | 2.3 | VIC |
| Edith Cowan University | Lauren | Blekkenhorst | $60,000 | Stronger evidence for the cardiovascular health benefits of specific vegetables and their bioactive compounds | 2.0 | WA |
| Monash University | Sam | Liao | $153,850 | Development of a rapid suture-less surgical implantation technique of ventricular assist devices to reduce postoperative bleeding and thrombosis | 2.0 | VIC |
| The University of Newcastle | Alice | Grady | $153,850 | Improving the health of pre-schoolers: Identifying and assessing the effectiveness of simple childcare-based obesity prevention interventions delivered at scale. | 2.0 | NSW |
| Deakin University | Laura | Alston | $120,960 | Reducing cardiovascular disease (CVD) burden in rural Australia for future generations: Targeting action from health services in driving prevention initiatives to improve diet and reduce CVDs for future generations. | 2.3 | VIC |
| University of Adelaide | Mohammadhossein | Hassanshahi | $153,850 | Defining the roles of adventitial haemangioblasts in stable and unstable atherosclerosis. | 2.0 | SA |
| Central Queensland University | Saman | Khalesi Taharoom | $153,850 | Reducing salt intake to improve hypertension using highly personalised web-based advice | 2.0 | QLD |
| Deakin University | Jonathan | Rawstorn | $153,850 | Broadening access to supervised exercise training for people with heart failure via innovative digital health technologies | 2.0 | VIC |
| University of Technology Sydney | Qian | Su | $60,000 | Imaging Profiling Platform for Thrombotic Disease and Anti-Platelet Therapeutics - new translational methodologies for characterising, identifying and monitoring thrombotic disease | 2.0 | NSW |
| University of New South Wales | Xiaoyue | Xu | $153,850 | Atrial Fibrillation in older women: exploring how diet and nutrition can improve outcomes | 2.0 | NSW |
| Central Queensland University | Stephanie | Alley | $153,850 | Increasing physical activity in older adults using a personally-tailored web-based physical activity intervention with social support | 2.0 | QLD |
| University of Tasmania | Jing | Tian | $153,850 | Understanding the determinants and cardiometabolic consequences of divergent adiposity trajectories from childhood to midlife: the International Childhood Cardiovascular Cohort (i3C) Consortium | 2.0 | TAS |
| Melbourne Health | Geoffrey | Wong | $153,850 | Genetic Susceptibility to Tachycardia-Mediated Cardiomyopathy Due To Atrial Arrhythmias (GENE-TCM Study) | 2.0 | VIC |
| University of Western Australia | Revathy | Carnagarin | $153,850 | Unravelling the role of the immune system in human hypertension | 2.0 | WA |
| University of New South Wales | Cheryl | Carcel | $173,850 | Providing explanations for the sex differences in cardiovascular mortality in Australia and evaluating the economic impact of strategies to reduce these inequities | 2.0 | NSW |
| Institute | First Name | Last Name | Funded Amount | Scientific Title | Duration (Years) | State |
|---|---|---|---|---|---|---|
| The University of Newcastle | Rebecca | Wyse | $150,000 | Harnessing digital innovation in High School Canteens to reduce cardiovascular dietary risk factors in adolescence: A pilot cluster randomised controlled trial. | 2.0 | NSW |
| University of New South Wales | Kerry-Anne | Rye | $150,000 | A Novel Approach for Preventing Cardiovascular Complications in Patients with Diabetes | 2.0 | NSW |
| University of New South Wales | Shane | Thomas | $150,000 | Heparanase as a novel therapeutic target for treating atherosclerosis | 2.0 | NSW |
| Baker Heart and Diabetes Institute | Quan | Huynh | $150,000 | Risk-guided Intervention to Reduce Heart Failure Readmission – the Risk-HF trial | 2.0 | VIC |
| Monash University | Chengxue | Qin | $149,922 | Formyl Peptide Receptor Agonist as Novel Therapy for Hypertension | 2.0 | VIC |
| The University of Queensland | Peter | Molenaar | $150,000 | Development and testing of new medicines in a human model of ventricular arrhythmias to keep heart failure patients alive | 2.0 | QLD |
| Baker Heart and Diabetes Institute | Julie | McMullen | $150,000 | A new drug delivery platform called Nano-Ghosts loaded with phosphoinositide 3-kinase (PI3K)-based drugs for the failing heart | 2.0 | VIC |
| Monash University | Francine | Marques | $149,960 | The role of gut pH in blood pressure regulation through G-coupled protein receptors | 2.0 | VIC |
| University of Sydney | Clara | Chow | $150,000 | Mass screening for AF among people aged 75 or older using handheld devices in a model integrated with cardiovascular services: A pilot study for feasibility and preliminary efficacy | 2.0 | NSW |
| University of Sydney | Belinda | Di Bartolo | $75,000 | What is the therapeutic efficacy of the novel P2X7R antagonist, SMW139, in attenuating diabetes associated -atherosclerosis and diabetic cardiomyopathy? | 1.0 | NSW |
| St Vincent’s Institute of Medical Research | Duncan | Campbell | $150,000 | Improving prevention of cardiovascular disease | 2.0 | VIC |
| Monash University | Dion | Stub | $150,000 | Lignocaine versus Opioids as analgesia In suspected STEMI (LIVE OASIS TRIAL) | 2.0 | VIC |
| University of Adelaide | Phillip | Tully | $150,000 | Collaborative depression care for coronary heart disease patients: a stepped-wedge RCT | 2.0 | SA |
| University of Adelaide | Peter | Psaltis | $145,000 | Defining the fate and roles of adventitial haemangioblasts in stable and unstable atherosclerosis. | 2.0 | SA |
| Flinders University | Robyn | Clark | $149,542 | Consumer co-creation and feasibility testing, of standardised ACS discharge and medication education, using Avatar technology, for patients and families with English as a second language and/or low health literacy, to prevent 30-day readmission. | 2.0 | SA |
| Curtin University | Eleanor | Quested | $149,646 | Can the Aussie-FIT healthy lifestyle intervention attract inactive men with cardiovascular disease and improve their health? A pilot and feasibility study in the context of Australian football | 2.0 | WA |
| University of Sydney | Anna | Waterhouse | $150,000 | Reducing thrombosis and bleeding in Ventricular Assist Devices | 2.0 | NSW |
| Monash University | Janet | Bray | $150,000 | Identifying strategies to improve survival from out-of-hospital cardiac arrest in Australia and New Zealand | 2.0 | VIC |
| Monash University | Graeme | Polglase | $141,600 | Improving cardiopulmonary resuscitation of neonates in the delivery room. | 2.0 | VIC |
| University of Sydney | Eddy | Kizana | $150,000 | Preclinical Assessment of Gene Therapy for Creation of a Biological Pacemaker | 2.0 | NSW |
| University of Sydney | James | Chong | $71,906 | Modulating cardiac scar formation and physical properties to treat heart failure: investigation of Tropoelastin as a novel therapeutic | 2.0 | NSW |
| University of Sydney | Saurabh | Kumar | $160,000 | Accuracy and Utility of Smartphone-based ECG Monitors for Diagnosis of Cardiac Arrhythmias | 2.0 | NSW |
| University of New South Wales | Susann | Beier | $149,632 | Optimization of Two Stent Bifurcation Techniques in Coronary Arteries | 2.0 | NSW |
| University of Sydney | Raymond | Sy | $150,000 | Non-invasive Markers to Assess QUInidine EffecT in Brugada Syndrome Study (The QUIET BrS Study) | 2.0 | NSW |
| Royal Brisbane and Women's Hospital Foundation | John | Atherton | $136,631 | Feasibility and Diagnostic Accuracy of Novel Echocardiographic Approaches to allow Screening and Monitoring for Left Ventricular Systolic Dysfunction by Novice Healthcare Staff | 2.0 | QLD |
Last updated08 January 2024